SAN FRANCISCO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies. Hagens Berman urges investors in ASP Isotopes who suffered substantial losses to submit your losses now. Class Period: Oct. 30, 2024 – Nov. 26, 2024Lead Plaintiff Deadline: Feb. 3, 2025Visit: www.hbsslaw.com/inve ...

NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ:ASPI) on behalf of ASP Isotopes stockholders. Our investigation concerns whether ASP Isotopes has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. A report from Fuzzy Panda Research alleged serious conc ...

WASHINGTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it will host an Investor Access Event in South Africa from January 14-16, 2025. All investors are invited to request a registration to attend the Investor Access Event. ASP Isotopes values transparency and open communication with ...

Core Viewpoint - The stock price of ASP Isotopes (NASDAQ: ASPI) plummeted by as much as 30% during intraday trading following a report from Fuzzy Panda Research alleging the company uses outdated technology and engages in stock promotion [1] Group 1: Allegations and Investigations - Fuzzy Panda Research published a report claiming ASP Isotopes is using old laser enrichment technology while presenting itself as a cutting-edge uranium enrichment company [3] - The report also alleged that ASP Isotopes employed individuals to promote its stock and that its technology was deemed "virtually worthless" by former Centrus executives [3] - Hagens Berman, a shareholder rights firm, has initiated an investigation into ASP Isotopes regarding its disclosures about its Aerodynamic Separation Process and Quantum Enrichment technology [2][4] Group 2: Market Reaction - Following the release of the report, ASP Isotopes' stock experienced a significant drop of 23% in a single trading day [3] - The price crash reflects investor concerns over the company's technology and potential misrepresentation of its commercial prospects [4] Group 3: Whistleblower Information - The investigation encourages whistleblowers with non-public information about ASP Isotopes to come forward, with potential rewards of up to 30% of any successful recovery made by the SEC [4]

Core Viewpoint - ASP Isotopes Inc. responds to a short seller report from Fuzzy Panda Research, asserting that the report contains inaccuracies and misleading claims about the company's technology and future growth potential [1][2]. Company Overview - ASP Isotopes Inc. is an advanced materials company focused on developing technology and processes for isotope production across various industries, employing proprietary Aerodynamic Separation Process (ASP technology) [5]. - The company is in the process of commissioning three isotope enrichment facilities in South Africa, targeting Carbon-14 for healthcare, Silicon-28 for semiconductors, and Ytterbium-176 for radio-oncology therapies [3][5]. Market Demand - There is an increasing demand for isotopes such as Silicon-28 for quantum computing, Molybdenum-100 and Molybdenum-98 for healthcare applications, and Uranium-235 for green energy [6]. Future Plans - ASP Isotopes plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology, which is currently under development [5]. - The company emphasizes transparency and will host a fireside chat with its CEO to discuss its operations and future strategies [4].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to __________________ Commission File Number: 001-41555 ASP Isotopes Inc. (Exact Name of Registrant as Specified in its Charter) Delaware ...

WASHINGTON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it has entered into a term sheet with TerraPower, a nuclear innovation company and advanced nuclear energy developer, related to the construction of a uranium enrichment facility capable of producing High Assay Low-Enriched Urani ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ____________________ FORM 10-Q ____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to __________________ Commission File Number: 001-41555 ASP Isotopes Inc. (Exact Name of Registrant ...

Investors are always on the hunt for the next big thing. Much like the internet revolution and the current AI boom, savvy investors look to get in early on the ground floor of the next world-changing trend. I believe a few under-the-radar companies have the ambition and growth potential to possibly be those next breakout stars.Some think we could see another major technological disruption within a few years. Others believe it may take decades. But in my view, it’s worth examining a handful of businesses tha ...

WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”) today announced the closing of the previously announced underwritten public offering of shares of its common stock. ASP Isotopes sold 13,800,000 shares of its common stock, which reflects the exercise in full by the underwriter of its option to purchase up to 1,800,000 additional shares of common stock, at a public offering price of $2.50 per share, less underwriting discounts and commissions.   Th ...